Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Class A Ordinary Shares, $0.0001 par value per share
-
Shares outstanding
-
15,139,982,333
-
Total 13F shares
-
2,559,111
-
Share change
-
+1,737,500
-
Total reported value
-
$1,662,875
-
Price per share
-
$0.6500
-
Number of holders
-
23
-
Value change
-
+$1,140,633
-
Number of buys
-
6
-
Number of sells
-
9
Institutional Holders of TRINITY BIOTECH PLC - Class A Ordinary Shares, $0.0001 par value per share (TRIB) as of Q2 2025
As of 30 Jun 2025 TRINITY BIOTECH PLC - Class A Ordinary Shares, $0.0001 par value per share (TRIB) had 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,559,111 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC, Whitefort Capital Management, LP, RENAISSANCE TECHNOLOGIES LLC, XTX Topco Ltd, Moss Adams Wealth Advisors LLC, RAYMOND JAMES FINANCIAL INC, Cambridge Investment Research Advisors, Inc., Williams & Novak, LLC, and BECKER CAPITAL MANAGEMENT INC.
This table shows 23 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.